Allogene Therapeutics Inc (ALLO)

Investing Cash Flow

-$147.56M

Quarterly · Period ending: · USD

ALLO logo

ALLO Investing Cash Flow

Latest reported-$147.56M
ALLO Quarterly Cash from Investing ($0.00 → -$147.56M)
High-resolution chart · PNG

ALLO investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Allogene Therapeutics Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
-147,559,000
-29,588,000
33,613,000
11,935,000
43,835,000
6,176,000
54,934,000
-75,992,000
74,613,000
22,133,000
67,461,000
-34,267,000
17,160,000
112,935,000
49,597,000
24,905,000
54,034,000
-22,377,000
29,250,000
13,013,000
24,594,000
96,798,000
22,210,000
-83,355,000
-428,971,000
-15,007,000
7,929,000
78,775,000
44,492,000
32,888,000
-313,388,000
-316,776,000
-2,634,000
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.